Under the agreement, Exact Sciences will pay Freenome an upfront cash payment of $75m that is payable by this November.

A groundbreaking blood test being studied in Virginia could detect 10 different types of cancer with a single screening, ...

James Van Der Beek is sharing the subtle colorectal cancer symptom he ignored before his shocking diagnosis. “There wasn’t ...

Illnesses like high blood pressure, diabetes, and glaucoma have hardly any symptoms before the damage has been done. Here, ...

A blood test being studied in Virginia could detect 10 different types of cancer with a single screening, potentially transforming early detection and treatment outcomes.

Red blood cells, long thought to be passive bystanders in the formation of blood clots, actually play an active role in ...

Key Points Revenue (GAAP) totaled $38,000 in Q1 2025. Net loss (GAAP) improved to $8.0 million in Q2 2025, with earnings per share (GAAP) at ($0.16) in Q2 2025 versus ($0.25) GAAP net loss per share ...

Exact Sciences stock crashed Wednesday after the company inked a deal for the exclusive eights to Freenome's blood-based ...

AN elderly man who has bone cancer is facing a 60-mile round trip to Carlisle to have blood tests completed after changes to GP practices ...

An Osaka Metropolitan University-led research team examined the medical records of 133 dogs that visited an emergency ...

Raising awareness of medical products and services is a marathon, not a sprint, and Babson Diagnostics has therefore selected a star with plenty of stamina for a long-term partnership. | Raising ...